The student entrepreneur who founded a microloans-for-poverty platform prepares for fraud trial in New York next month.

The Genetic Signatures share price suffers from the company's lack of profitability, but it may be on the verge of big international growth.

Hundred million-dollar investment in intermediate care option between GPs and hospitals expected to be touchstone in federal election.